Novo Nordisk shares rise after copy pill cancellation
Novo Nordisk’s stock has experienced volatility, initially dropping steeply and then rising steadily. On Monday, shares increased by over eight percent. This rise follows Hims & Hers’ decision to stop selling a copy of Novo’s Wegovy pill, which they had announced for a launch at $49 monthly – a third of Novo’s price. The announcement […]